In the last 12 months, insiders at GeoVax Labs, Inc. ($GOVX) filed 49 transactions with the SEC: 16 open-market purchases totaling $139,227 and 0 sales totaling $0. Net insider sentiment: net buying.
GeoVax Labs, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- DODD DAVID A (President, CEO) — 9 transactions totaling $86,626
- Reynolds Mark (CFO) — 7 transactions totaling $23,102
- SPENCER JOHN N JR (Director) — 5 transactions totaling $15,298
- McKee Kelly T. Jr. (Chief Medical Officer) — 6 transactions totaling $8,261
- Sharkey John W. (VP, Business Development) — 4 transactions totaling $5,940
View all SEC Filings for GeoVax Labs, Inc. (GOVX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 17, 2025 | SPENCER JOHN N JR | Director | P | Common Stock | 10000 | $0.55 | 21,402.0000 | 29,705,360 | 87.70% | 0.03% |
| Aug. 7, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | P | Common Stock | 1107 | $0.67 | 3,494.0000 | 10,536,875 | 46.38% | 0.01% |
| June 5, 2025 | CHASE RANDAL D | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | Kollintzas Dean G | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | MCNALLY ROBERT T | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | Morgan Jayne | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | SPENCER JOHN N JR | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | NEWMAN MARK J | Chief Scientific Officer | A | Stock Option | 70000 | $0.00 | 70,000.0000 | 10,536,875 | 9999.99% | 0.66% |
| June 5, 2025 | Reynolds Mark | CFO | A | Stock Option | 70000 | $0.00 | 70,000.0000 | 10,536,875 | 9999.99% | 0.66% |
| June 5, 2025 | Lemerond Nicole | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 10,536,875 | 9999.99% | 0.09% |
| June 5, 2025 | DODD DAVID A | President, CEO | A | Stock Option | 185500 | $0.00 | 185,500.0000 | 10,536,875 | 9999.99% | 1.76% |
| June 5, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | A | Stock Option | 70000 | $0.00 | 70,000.0000 | 10,536,875 | 9999.99% | 0.66% |
| June 5, 2025 | Sharkey John W. | VP, Business Development | A | Stock Option | 70000 | $0.00 | 70,000.0000 | 10,536,875 | 9999.99% | 0.66% |
| April 10, 2025 | SPENCER JOHN N JR | Director | P | Common Stock | 10000 | $0.98 | 11,402.0000 | 10,536,875 | 713.27% | 0.09% |
| April 10, 2025 | Sharkey John W. | VP, Business Development | P | Common Stock | 6000 | $0.99 | 6,191.0000 | 10,536,875 | 3141.36% | 0.06% |
| April 1, 2025 | DODD DAVID A | President, CEO | P | Common Stock | 10000 | $1.08 | 36,661.0000 | 10,536,875 | 37.51% | 0.09% |
| March 31, 2025 | Reynolds Mark | CFO | P | Common Stock | 6800 | $1.08 | 14,013.0000 | 10,536,875 | 94.27% | 0.06% |
| Aug. 12, 2024 | CHASE RANDAL D | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 12, 2024 | MCNALLY ROBERT T | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 12, 2024 | Morgan Jayne | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 12, 2024 | DODD DAVID A | President, CEO | A | Stock Option | 35000 | $0.00 | 35,000.0000 | 1,977,152 | 9999.99% | 1.77% |
| Aug. 12, 2024 | McKee Kelly T. Jr. | Chief Medical Officer | A | Stock Option | 15700 | $0.00 | 15,700.0000 | 1,977,152 | 9999.99% | 0.79% |
| Aug. 12, 2024 | NEWMAN MARK J | Chief Scientific Officer | A | Stock Option | 15700 | $0.00 | 15,700.0000 | 1,977,152 | 9999.99% | 0.79% |
| Aug. 12, 2024 | Reynolds Mark | CFO | A | Stock Option | 15700 | $0.00 | 15,700.0000 | 1,977,152 | 9999.99% | 0.79% |
| Aug. 12, 2024 | Sharkey John W. | VP, Business Development | A | Stock Option | 15700 | $0.00 | 15,700.0000 | 1,977,152 | 9999.99% | 0.79% |
| Aug. 12, 2024 | SPENCER JOHN N JR | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 12, 2024 | Kollintzas Dean G | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 12, 2024 | Lemerond Nicole | Director | A | Stock Option | 8050 | $0.00 | 8,050.0000 | 1,977,152 | 9999.99% | 0.41% |
| Aug. 9, 2024 | DODD DAVID A | President, CEO | P | Common Stock | 8000 | $1.95 | 26,661.0000 | 1,977,152 | 42.87% | 0.40% |
| Feb. 22, 2024 | DODD DAVID A | President, CEO | P | Common Stock | 8209 | $2.27 | 18,661.0000 | 1,977,152 | 78.54% | 0.42% |
| Feb. 21, 2024 | DODD DAVID A | President, CEO | P | Common Stock | 520 | $2.15 | 10,452.0000 | 1,977,152 | 5.24% | 0.03% |
| Feb. 7, 2024 | Reynolds Mark | CFO | P | Common Stock | 2000 | $2.77 | 7,213.0000 | 1,977,152 | 38.37% | 0.10% |
| Dec. 22, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | P | Common Stock | 6944 | $0.36 | 35,782.0000 | 0 | 24.08% | 0.00% |
| Sept. 25, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | P | Common Stock | 9653 | $0.52 | 28,838.0000 | 0 | 50.32% | 0.00% |
| Aug. 25, 2023 | DODD DAVID A | President, CEO | P | Common Stock | 35087 | $0.57 | 148,957.0000 | 0 | 30.81% | 0.00% |
| Aug. 18, 2023 | Reynolds Mark | CFO | P | Common Stock | 10000 | $0.52 | 78,184.0000 | 0 | 14.67% | 0.00% |
| Aug. 1, 2023 | Morgan Jayne | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Lemerond Nicole | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | MCNALLY ROBERT T | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | SPENCER JOHN N JR | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | A | Stock Option | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Sharkey John W. | VP, Business Development | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | NEWMAN MARK J | Chief Scientific Officer | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | DODD DAVID A | President, CEO | A | Stock Option | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Reynolds Mark | CFO | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Kollintzas Dean G | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | CHASE RANDAL D | Director | A | Stock Option | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 24, 2023 | DODD DAVID A | President, CEO | P | Common Stock | 32000 | $0.64 | 113,870.0000 | 0 | 39.09% | 0.00% |
| April 20, 2023 | Reynolds Mark | CFO | P | Common Stock | 8000 | $0.63 | 68,184.0000 | 0 | 13.29% | 0.00% |